Thank you very much, Mr. Chair.
I'm very keenly interested. We've heard now, through the minister's touting significant purchases and options for purchase, and I'm wondering about her comments on the equity policy for being able to procure vaccines.
I'm wondering what the staff's thoughts are on the fact that 80% of the vaccine doses have been bought by European and North American countries representing only 14% of the global population. Could they comment on exactly what our plan is for the surplus vaccines that we have options for, and purchasing of, as it relates to the global COVAX Facility?